Tag Archives: DDMAC

Genentech Runs Voluntary Corrective Ads for Boniva

By Ben Comer | Published: January 18, 2012
Even though Roche-owned Genentech wasn’t required to run costly corrective advertisements following an FDA Untitled Letter on Boniva last January, the company has done so anyway.
Posted in Advertising, Corporate Responsibility, FDA, Legal, Marketing, Regulatory, compliance, leadership | Also tagged , , | Leave a comment

DIA: Social Media Guidelines are DDMAC’s "Highest Priority"

By Ben Comer | Published: June 22, 2011
Tom Abrams, director of FDA’s Division (soon to be Office) of Drug Marketing, Advertising & Communications (DDMAC), said that publishing social media guidelines for industry is the division’s “highest priority,” and that the document will be “published as soon as it’s vetted.”
Posted in Advertising, E-Media, FDA, Marketing, Meetings, Regulatory, Strategy, Technology, patient education, social media | Also tagged , | 1 Comment

Bad Ad: One Year of Fear

By Ben Comer | Published: June 13, 2011
FDA’s Bad Ad program, launched in May of 2010, resulted in some 328 reports of potentially untruthful or misleading promotion, a handful of Warning Letters, and several Untitled Letters. But the single most effective tool in the Bad Ad program’s toolkit, according to Arnie Friede, principal at Arnold I. Friede & Associates, and a former associate [...]
Posted in Advertising, Corporate Responsibility, FDA, Legal, Marketing, Regulatory, compliance | Also tagged , , | Leave a comment

New FDA Campaign Targets Detailing, Trade Shows

By Jill Wechsler | Published: May 19, 2010
In addition to sending out more warning letters and stepping up enforcement activity, the Food and Drug Administration wants health professionals to do more to police drug marketing and advertising. The agency’s “Bad Ad” program urges doctors and other health professionals to report any false or misleading ads or inappropriate marketing pitches. Depending on one’s [...]
Posted in FDA, News, Regulatory | Also tagged , , , , , | Leave a comment

Building a Better Brief Summary

By George Koroneos | Published: June 25, 2009
Image via Wikipedia FDA wanted to find out what people really think of the risk information printed on the back of pharmaceutical advertising. Surprise, people tend to absorb far less information from the giant blocks of text printed in drab language. DDMAC social science analyst Amy O’Donoghue explained FDA’s recent study results to an audience of marketers [...]
Posted in Advertising, Regulatory | Also tagged , , , , | 4 Comments